Breaking News Instant updates and real-time market news.

EVA

Enviva

$30.82

0.32 (1.05%)

10:35
10/15/18
10/15
10:35
10/15/18
10:35

Enviva: Facilities incured 'limited' damage from Hurricane Michael

Enviva Partners reported that its facilities incurred only limited damage from Hurricane Michael. The Partnership undertook substantial preparation in advance of Hurricane Michael's landfall to keep employees safe and minimize disruption, including proactively idling operations at its wood pellet production plant in Jackson County, Florida and a third-party deep-water marine terminal in Panama City, Florida. Based on initial assessments, the Cottondale plant did not incur substantial wind or water damage. Although the Partnership does not own material infrastructure assets at the Panama City terminal, a small portion of the roof on its contracted storage warehouse will need to be replaced and an estimated 5,000 tons of wood pellet inventory stored at the terminal appear to have been damaged by wind and rain. The Partnership's production facilities and inventory are insured under a comprehensive insurance program. The Cottondale plant is prepared to return to operations once power is restored to the site, which is expected to occur within the next week. Although the Port of Panama City remains closed, the Partnership is making arrangements to transport wood pellets from the Cottondale plant to other terminals. As a result, the Partnership expects Hurricane Michael to temporarily delay portions of its shipping schedule. The Partnership will continue to assess any impact on ship timing and operations as the region recovers.

EVA Enviva
$30.82

0.32 (1.05%)

05/14/18
RBCM
05/14/18
NO CHANGE
Target $33
RBCM
Outperform
Enviva price target lowered to $33 from $37 at RBC Capital
RBC Capital analyst Elvira Scotto lowered her price target on Enviva to $33 after its Q1 earnings miss, saying the results were "noisy" because of the costs associated with the Chesapeake terminal fire. The analyst notes however that Chesapeake expects to recover those costs and achieve its FY18 guidance. Scotto also keeps her Outperform rating on Enviva based on its status of a "leading supplier of utility-grade wood pellets" and its "highly visible top-tier distribution growth" over the coming years.

TODAY'S FREE FLY STORIES

CMA

Comerica

$65.50

-1.505 (-2.25%)

07:13
10/17/19
10/17
07:13
10/17/19
07:13
Downgrade
Comerica rating change  »

JPMorgan downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCBI

Texas Capital

$54.33

-0.15 (-0.28%)

07:12
10/17/19
10/17
07:12
10/17/19
07:12
Recommendations
Texas Capital analyst commentary  »

Texas Capital price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRK

Merck

$84.46

-0.59 (-0.69%)

07:11
10/17/19
10/17
07:11
10/17/19
07:11
Initiation
Merck initiated  »

Merck reinstated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 23

    Oct

  • 29

    Oct

  • 06

    Nov

  • 24

    Jan

  • 24

    Jan

  • 14

    Mar

PM

Philip Morris

$79.12

0.8 (1.02%)

07:11
10/17/19
10/17
07:11
10/17/19
07:11
Hot Stocks
Philip Morris backs FY19 currency-neutral net revenue growth of at least 6% »

Lowers FY19 capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

GOLD

Barrick Gold

$16.95

0.3 (1.80%)

07:11
10/17/19
10/17
07:11
10/17/19
07:11
Hot Stocks
Barrick Gold sees FY production towards upper end of 5.1M-5.6M ounce guidance »

Barrick Gold Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

PFE

Pfizer

$36.34

-0.17 (-0.47%)

07:10
10/17/19
10/17
07:10
10/17/19
07:10
Initiation
Pfizer initiated  »

Pfizer reinstated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 06

    Nov

GILD

Gilead

$65.36

0.02 (0.03%)

07:08
10/17/19
10/17
07:08
10/17/19
07:08
Initiation
Gilead initiated  »

Gilead reinstated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 06

    Nov

MAIN

Main Street

$42.08

0.155 (0.37%)

07:08
10/17/19
10/17
07:08
10/17/19
07:08
Earnings
Main Street declares semi-annual supplemental cash dividend of 24c in December »

Main Street declared its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

POOL

Pool Corp.

$200.56

-4.63 (-2.26%)

07:08
10/17/19
10/17
07:08
10/17/19
07:08
Earnings
Pool Corp. raises FY19 EPS view $6.20-$6.40 from $6.09-$6.34 

Consensus $6.22.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 13

    Nov

PM

Philip Morris

$79.12

0.8 (1.02%)

07:08
10/17/19
10/17
07:08
10/17/19
07:08
Hot Stocks
Philip Morris revises FY19 shipment volume assumption to "down 1% - down 1.5" »

Prior guidance was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

BIIB

Biogen

$227.79

1.75 (0.77%)

07:07
10/17/19
10/17
07:07
10/17/19
07:07
Initiation
Biogen initiated  »

Biogen reinstated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

AZN

AstraZeneca

$43.80

-0.41 (-0.93%)

07:07
10/17/19
10/17
07:07
10/17/19
07:07
Hot Stocks
AstraZeneca says trastuzumab deruxtecan granted FDA Priority Review »

AstraZeneca and Daiichi…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 06

    Nov

POOL

Pool Corp.

$200.56

-4.63 (-2.26%)

07:07
10/17/19
10/17
07:07
10/17/19
07:07
Earnings
Pool Corp. reports Q3 EPS ex-items $1.84, consensus $1.78 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 13

    Nov

TXMD

TherapeuticsMD

$3.70

-0.22 (-5.61%)

07:05
10/17/19
10/17
07:05
10/17/19
07:05
Initiation
TherapeuticsMD initiated  »

TherapeuticsMD initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PM

Philip Morris

$79.12

0.8 (1.02%)

07:05
10/17/19
10/17
07:05
10/17/19
07:05
Earnings
Philip Morris lowers FY19 EPS view to 'at least $4.73' from 'at least $4.94' »

Consensus $5.21. The…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

NFLX

Netflix

$286.83

2.59 (0.91%)

07:05
10/17/19
10/17
07:05
10/17/19
07:05
Recommendations
Netflix analyst commentary  »

KeyBanc lowers estimates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

NBRV

Nabriva Therapeutics

$2.01

0.08 (4.15%)

07:05
10/17/19
10/17
07:05
10/17/19
07:05
Conference/Events
Nabriva Therapeutics management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

BBIO

BridgeBio

$17.92

-0.6 (-3.24%)

07:05
10/17/19
10/17
07:05
10/17/19
07:05
Hot Stocks
BridgeBio reports preclinical data on infigratinib in treating achondroplasia »

BridgeBio Pharma and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$203.28

-1.37 (-0.67%)

07:05
10/17/19
10/17
07:05
10/17/19
07:05
Initiation
Amgen initiated  »

Amgen reinstated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 06

    Nov

UCBJY

UCB

$0.00

(0.00%)

07:05
10/17/19
10/17
07:05
10/17/19
07:05
Hot Stocks
UCB says bimekizumab Phase 3 psoriasis study meets all endpoints »

UCB announced positive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SASR

Sandy Spring Bancorp

$33.42

0.21 (0.63%)

07:04
10/17/19
10/17
07:04
10/17/19
07:04
Earnings
Sandy Spring Bancorp reports Q3 EPS 82c, consensus 80c »

"In the third…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

AUG

Auryn Resources

$1.28

0.09 (7.56%)

07:02
10/17/19
10/17
07:02
10/17/19
07:02
Hot Stocks
Auryn Resources stakes additional claims at Sombrero North project area »

Auryn Resources announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNC

Centene

$45.53

0.33 (0.73%)

, WBA

Walgreens Boots Alliance

$54.66

0.15 (0.28%)

07:02
10/17/19
10/17
07:02
10/17/19
07:02
Hot Stocks
Centene, Walgreens Boots Alliance, RxAdvance announce partnership »

Centene (CNC), Walgreens…

CNC

Centene

$45.53

0.33 (0.73%)

WBA

Walgreens Boots Alliance

$54.66

0.15 (0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 25

    Oct

  • 28

    Oct

  • 28

    Oct

  • 29

    Oct

  • 30

    Oct

  • 31

    Oct

MIST

Milestone Pharmaceuticals

$18.75

0.25 (1.35%)

07:02
10/17/19
10/17
07:02
10/17/19
07:02
Conference/Events
Milestone Pharmaceuticals management to meet with Piper Jaffray »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

PM

Philip Morris

$79.12

0.8 (1.02%)

07:02
10/17/19
10/17
07:02
10/17/19
07:02
Earnings
Philip Morris reports Q3 adjusted EPS $1.43, consensus $1.36 »

Reports Q3 net revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.